Article Text

Download PDFPDF
Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke
  1. Sujoy Ghosh,
  2. Arjun Kumar Ghosh,
  3. Sandip Kumar Ghosh
  1. Ayr Hospital, Ayr, Ayrshire, UK
  1. Correspondence to:
 Sandip Kumar Ghosh
 Ayr Hospital, Dalmellington Road, Ayr, Ayrshire KA6 6DX, UK; sandy.ghosh{at}


Up to 40% of acute ischaemic strokes in young adults are cryptogenic in nature, that is, no cause is determined. In more than half of these patients, patent foramen ovale (PFO) is seen along with an increased incidence of atrial septal aneurysm. The commonest method of investigation is echocardiography (preferably transoesophageal echocardiography). On the basis of available evidence, low risk patients are treated with antiplatelet agents and high risk patients with warfarin. There are inconclusive data on the efficacy of PFO closure to prevent stroke recurrence. However, if there is recurrent stroke or intolerance to medical therapy, percutaneous closure is carried out.

  • ASA, atrial septal aneurysm
  • PFO, patent foramen ovale
  • TIA, transient ischaemic attack
  • TOE, transoesophageal echocardiography
  • TTE, transthoracic echocardiography
  • atrial septal defect
  • cryptogenic stroke
  • patent foramen ovale

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None declared.